Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Oji

Showing results (521-530 of 589) with videos related to

Pageof 59
Sort By:
Plos One|March 25, 2016
Glycosylation Status of CD43 Protein Is Associated with Resistance of Leukemia Cells to CTL-Mediated CytolysisKana Hasegawa, Satomi Tanaka, Fumihiro Fujiki, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 21, 2017
TCTE1 is a conserved component of the dynein regulatory complex and is required for motility and metabolism in mouse spermatozoaJulio M Castaneda, Rong Hua, Haruhiko Miyata, et al.
Blood|April 20, 2002
Humoral immune responses against Wilms tumor gene WT1 product in patients with hematopoietic malignanciesOlga A Elisseeva, Yoshihiro Oka, Akihiro Tsuboi, et al.
Advanced Materials (Deerfield Beach, Fla.)|April 5, 2026
Versatile Magneto-Dielectric Response of Epitaxial Thin Films of the High Entropy Oxide Perovskite Nd(Cr<sub>0.2</sub>Mn<sub>0.2</sub>Fe<sub>0.2</sub>Co<sub>0.2</sub>Ni<sub>0.2</sub>)O<sub>3</sub>Roxana Capu, Ryan Thompson, C Willem Rischau, et al.
Leukemia|March 21, 2012
CD138-negative clonogenic cells are plasma cells but not B cells in some multiple myeloma patientsN Hosen, Y Matsuoka, S Kishida, et al.
Blood Cancer Journal|March 31, 2019
Mice with Calr mutations homologous to human CALR mutations only exhibit mild thrombocytosisKotaro Shide, Takuro Kameda, Ayako Kamiunten, et al.
Journal of Neurosurgery|May 2, 2008
Phase II clinical trial of Wilms tumor 1 peptide vaccination for patients with recurrent glioblastoma multiformeShuichi Izumoto, Akihiro Tsuboi, Yoshihiro Oka, et al.
European Journal of Haematology|June 10, 2022
Prevalence of venous thromboembolism and its associations in a large racially homogenous population of sickle cell disease patientsHelen Chioma Okoye, Chinedu Ezekekwu, Theresa Ukamaka Nwagha, et al.
Cancer Science|July 13, 2004
Overexpression of the Wilms' tumor gene WT1 in pancreatic ductal adenocarcinomaYusuke Oji, Shoji Nakamori, Masahiro Fujikawa, et al.
Leukemia|November 13, 2004
Th1-biased humoral immune responses against Wilms tumor gene WT1 product in the patients with hematopoietic malignanciesF Wu, Y Oka, A Tsuboi, et al.
Pageof 59

Showing results (521-530 of 589) with videos related to

Sort By:
Pageof 59
Plos One|March 25, 2016
Glycosylation Status of CD43 Protein Is Associated with Resistance of Leukemia Cells to CTL-Mediated CytolysisKana Hasegawa, Satomi Tanaka, Fumihiro Fujiki, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 21, 2017
TCTE1 is a conserved component of the dynein regulatory complex and is required for motility and metabolism in mouse spermatozoaJulio M Castaneda, Rong Hua, Haruhiko Miyata, et al.
Blood|April 20, 2002
Humoral immune responses against Wilms tumor gene WT1 product in patients with hematopoietic malignanciesOlga A Elisseeva, Yoshihiro Oka, Akihiro Tsuboi, et al.
Advanced Materials (Deerfield Beach, Fla.)|April 5, 2026
Versatile Magneto-Dielectric Response of Epitaxial Thin Films of the High Entropy Oxide Perovskite Nd(Cr<sub>0.2</sub>Mn<sub>0.2</sub>Fe<sub>0.2</sub>Co<sub>0.2</sub>Ni<sub>0.2</sub>)O<sub>3</sub>Roxana Capu, Ryan Thompson, C Willem Rischau, et al.
Leukemia|March 21, 2012
CD138-negative clonogenic cells are plasma cells but not B cells in some multiple myeloma patientsN Hosen, Y Matsuoka, S Kishida, et al.
Blood Cancer Journal|March 31, 2019
Mice with Calr mutations homologous to human CALR mutations only exhibit mild thrombocytosisKotaro Shide, Takuro Kameda, Ayako Kamiunten, et al.
Journal of Neurosurgery|May 2, 2008
Phase II clinical trial of Wilms tumor 1 peptide vaccination for patients with recurrent glioblastoma multiformeShuichi Izumoto, Akihiro Tsuboi, Yoshihiro Oka, et al.
European Journal of Haematology|June 10, 2022
Prevalence of venous thromboembolism and its associations in a large racially homogenous population of sickle cell disease patientsHelen Chioma Okoye, Chinedu Ezekekwu, Theresa Ukamaka Nwagha, et al.
Cancer Science|July 13, 2004
Overexpression of the Wilms' tumor gene WT1 in pancreatic ductal adenocarcinomaYusuke Oji, Shoji Nakamori, Masahiro Fujikawa, et al.
Leukemia|November 13, 2004
Th1-biased humoral immune responses against Wilms tumor gene WT1 product in the patients with hematopoietic malignanciesF Wu, Y Oka, A Tsuboi, et al.
Pageof 59